Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
This acquisition enhances Progyny's guided, concierge support that enables employees around the world to navigate the compl...
Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and lowers the price target from $46 to...
Cantor Fitzgerald analyst Sarah James reiterates Progyny (NASDAQ:PGNY) with a Overweight and maintains $48 price target.
Barclays analyst Sarah James maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $48 to $30.
Canaccord Genuity analyst Richard Close maintains Progyny (NASDAQ:PGNY) with a Buy and lowers the price target from $46 to $37.
Progyny reported first-quarter sales of $278.1 million, slightly below expectations due to increased clients and covered lives....
